Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 152,406 | 169,506 | 169,394 | 154,108 | 178,689 |
| Marketable Securities | N/A | 14,947 | 48,651 | 97,581 | 111,421 |
| TOTAL | $157,208 | $188,165 | $221,130 | $254,836 | $292,722 |
| Non-Current Assets | |||||
| PPE Net | 8,706 | 9,303 | 9,521 | 8,351 | 7,242 |
| Investments And Advances | 101 | 288 | 1,782 | 1,755 | 1,766 |
| Other Non-Current Assets | 62,774 | 64,469 | 66,128 | 67,767 | 69,388 |
| TOTAL | $71,581 | $74,060 | $77,431 | $77,873 | $78,396 |
| Total Assets | $228,789 | $262,225 | $298,561 | $332,709 | $371,118 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,241 | 6,353 | 4,539 | 4,966 | 4,278 |
| Accrued Expenses | 7,668 | 10,765 | 12,797 | 9,607 | 15,410 |
| TOTAL | $18,695 | $29,208 | $31,322 | $29,816 | $35,956 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,534 | 32,414 | 32,296 | 32,182 | 32,072 |
| Deferred Revenues | 2,619 | 5,186 | 7,698 | 10,272 | 11,698 |
| Other Non-Current Liabilities | 54,437 | 56,582 | 58,229 | 60,008 | 60,874 |
| TOTAL | $86,971 | $88,996 | $90,525 | $92,691 | $94,192 |
| Total Liabilities | $105,666 | $118,204 | $121,847 | $122,507 | $130,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,902 | 56,748 | 56,748 | 56,591 | 56,591 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -504,862 | -481,885 | -446,175 | -409,223 | -375,096 |
| Other shareholders' equity | 0 | 2 | -4 | -4 | 51 |
| TOTAL | $123,123 | $144,021 | $176,714 | $210,202 | $240,970 |
| Total Liabilities And Equity | $228,789 | $262,225 | $298,561 | $332,709 | $371,118 |